A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients with Pulmonary Arterial Hypertension (STRIDE-III)

Grants and Contracts Details

StatusFinished
Effective start/end date2/2/0412/31/09

Funding

  • ENCYSIVE LP admin by ResearchPoint: $58,871.00